These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5263687)

  • 1. Genetic variations in the acetylation of isoniazid and other drugs.
    Evans DA
    Ann N Y Acad Sci; 1968 Jul; 151(2):723-33. PubMed ID: 5263687
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 3. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent progress in pharmacogenetics.
    Vesell ES
    Adv Pharmacol (1962); 1969; 7():1-52. PubMed ID: 4190237
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
    S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigations into the polymorphism of acetylation of isonicotinic acid hydrazid (INH)].
    Goedde HW; Schloot W
    Med Welt; 1968 Dec; 51():2812-21. PubMed ID: 5752425
    [No Abstract]   [Full Text] [Related]  

  • 7. Four-drug initial therapy for TB is standard treatment.
    Brennan PJ; MacGregor RR
    Pa Med; 1996 Jan; 99(1):18-9. PubMed ID: 8927398
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience of intermittent treatment in the United Kingdom.
    Stradling P
    Tubercle; 1968 Mar; 49():Suppl:83-5. PubMed ID: 4872962
    [No Abstract]   [Full Text] [Related]  

  • 9. The frequency of isoniazid acetylase enzyme deficiency among Egyptians.
    Hashem N; Khalifa S; Nour A
    Am J Phys Anthropol; 1969 Jul; 31(1):97-101. PubMed ID: 5800907
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid acetylator status of Black South African tuberculosis patients.
    Bach PH; Higgins-Opitz SB; Bima B; Leary WP
    S Afr Med J; 1976 Jul; 50(29):1132-4. PubMed ID: 959925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of treatment of drug resistance in the developing countries.
    Fox W
    Tubercle; 1969 Mar; 50():Suppl:55-65. PubMed ID: 5402546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug reactions and human genetics].
    Sunahara S
    Saishin Igaku; 1967 Dec; 22(12):2653-61. PubMed ID: 4875701
    [No Abstract]   [Full Text] [Related]  

  • 17. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 19. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
    Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
    Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hong Kong tuberculosis treatment services/British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis.
    Allan WG
    Bull Int Union Tuberc; 1976; 51(1):91-3. PubMed ID: 1030317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.